Positions

Assistant Professor
Ophthalmology-Departmental
Baylor College of Medicine
Houston, Texas, US
Staff Physician
Ophthalmology-Departmental
Ben Taub Hospital

Education

Fellowship at Bascom Palmer Eye Institute-University of Miami
Residency at Johns Hopkins University-Wilmer Eye Institute
MD from University of Michigan Medical School
MBA from University of Michigan Ross School of Business
BA from Northwestern University

Certifications

American Board of Ophthalmology
Alpha Omega Alpha
Texas Medical Board

Professional Interests

  • Vitreoretinal Diseases and Surgery
  • Macular Degeneration
  • Diabetic Retinopathy
  • Retinal Detachment
  • Retinal Vein Occlusion
  • Epiretinal Membrane
  • Macular Hole
  • Floaters
  • Retina
  • Central Serous Retinopathy
  • Macular Edema

Professional Statement

My work focuses on analyzing and improving the quality of clinical and surgical care in the field of retinal diseases. I am passionate about improving the quality of life for my patients by preserving and restoring their vision, but am also very interested in treating people on a larger scale. One way of doing so is by evaluating treatment outcomes across populations, and then identifying factors that contribute to excellent outcomes. I also specialize in the medical and surgical management of complex conditions including retinal detachment, epiretinal membrane, floaters, macular degeneration, and diabetic retinopathy.

Selected Publications

  • Weng, C.Y., Gregori, N.Z., Moysidis, S.N., Shi, W., Smiddy, W.E., Flynn, Jr., H.W.. "Visual and Anatomic Outcomes of Macular Epiretinal Membrane Peeling After Previous Rhegmatogenous Retinal Detachment Repair." RETINA.
  • Weng, C.Y., Harbour, J.W.. "38 Year-Old Female Presenting with Serous Macular Detachment Following a Systemic Corticosteroid Injection." JAMA Ophthalmology.
  • Weng, C.Y., Parke III, D.W., Walter, S.D., Isom, R.F., Chang, J.S., Flynn, Jr., H.W.. "Candida glabrata Endophthalmitis Transmitted From Graft to Host After Descemet Stripping Automated Endothelial Keratoplasty." JAMA Ophthalmology.
  • Weng, C.Y., Flynn, Jr., H.W.. "Retinal Imaging in Peri-Macular Degenerative Retinoschisis." Ophthalmic Surgery, Laser and Imaging-Retina.
  • Weng, C.Y., Fortun, J.A., Carvounis, P.E., Albini, T.A.. "Ocriplasmin & Its Role in the Management of Vitreoretinal Interface Disorders." International Ophthalmology Clinics.
  • Weng, C.Y., Kothary, P.C., Verkade, A.J., Reed, D.M., Del Monte, M.A.. "MAP kinase pathway is involved in IGF-1-stimulated proliferation of human retinal pigment epithelial cells (hRPE)." Current Eye Research.
  • Weng, C.Y., Berrocal, A.M.. "Traumatic Macular Holes in the Pediatric and Adolescent Populations." Retinal Physician.
  • Kothary, P.C., Badhwar, J., Weng, C., Del Monte, M.A.. "Impaired Intracellular Signaling May Allow Up-Regulation of CTGF-Synthesis and Secondary Peri-Retinal Fibrosis in Human Retinal Pigment Epithelial Cells from Patients with Age-Related Macular Degeneration." Advances in Experimental Medicine and Biology.

Memberships

American Academy of Ophthalmology
American Society of Retina Specialists
Association for Research in Vision and Ophthalmology
Houston Ophthalmological Society
American Academy of Ophthalmic Executives
Alpha Omega Alpha

Skills

Repair of retinal detachment
A retinal detachment is when the retina is separated from its proper position, and can be potentially blinding if not treated urgently.
Treatment of macular edema
Macular edema is swelling of the retina and can occur due to diabetes, retinal vein occlusion, previous eye surgery, amongst other reasons. It is visually-threatening, but often can be treated.
Management of macular degeneration
Macular degeneration occurs commonly in patients over the age of 50, and is a leading cause of vision loss in the world. Fortunately, there has been significant progress in treatment options.
Management of diabetic retinopathy
Diabetic retinopathy can occur in anybody who has diabetes (high blood sugar). In its earliest form, the patient may not know that he/she has it. Therefore, it is critical that patients are evaluated annually to screen for this disease. When discovered early, blindness is largely preventable.